Inovalon Holdings, Inc. INOV

Inovalon Holdings, Inc. Revenue 2011-2026 | INOV

Company revenue is the total amount of money received from the sale of goods or services over a certain period of time. It is one of the key indicators of a company's financial condition and success.

Traditionally defined as follows:
Revenue = Price * Quantity of products

Revenue is one of the components of a company’s income. In international practice, revenue is understood as the inflow or other increase in a company's assets or the settlement of its obligations that occurs as a result of the company’s core or main activity.^[1]

This is an important indicator for assessing the financial condition and efficiency of a company. It makes it possible to determine how successfully a company sells its products or services on the market. In addition, revenue can be used to calculate other financial indicators such as profit, profitability, and market share.

Various factors can influence this indicator, including demand for goods or services, market competition, economic conditions, and the company's marketing efforts. Therefore, its analysis and monitoring are important tasks for the successful development of a business.

Annual Revenue Inovalon Holdings, Inc.

2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
668 M	642 M	528 M	449 M	428 M	437 M	362 M	296 M	300 M	240 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
668 M	240 M	435 M

References

Adhikari, B. (2010). Impact of Revenue Planning In Nepal Investment Bank Limited (Doctoral dissertation, Faculty of Management).

Revenue of other stocks in the Health information services industry

Issuer	Revenue	Price	% 24h	Market Cap	Country
Cerner Corporation CERN	5.76 B	-	-	$ 27.9 B	USA
Covetrus CVET	4.58 B	-	-	$ 2.94 B	USA
Computer Programs and Systems CPSI	339 M	-	4.4 %	$ 133 M	USA
Accolade ACCD	170 M	-	0.29 %	$ 206 M	USA
Castlight Health, Inc. CSLT	147 M	-	-7.28 %	$ 227 M	USA
HMS Holdings Corp. HMSY	673 M	-	-	$ 3.29 B	USA
Change Healthcare CHNG	3.09 B	-	-	$ 9.03 B	USA
iCAD ICAD	19.6 M	-	-	$ 102 M	USA
Evolent Health EVH	382 M	$ 3.92	-3.45 %	$ 367 M	USA
Health Catalyst HCAT	307 M	$ 2.37	-0.63 %	$ 143 M	USA
HealthStream HSTM	292 M	$ 23.05	-0.95 %	$ 700 M	USA
Akerna Corp. KERN	20.5 M	-	-	$ 161 M	USA
MTBC MTBC	111 M	-	-0.58 %	$ 51.7 M	USA
HealthEquity HQY	262 M	$ 91.41	-1.18 %	$ 7.82 B	USA
Progyny PGNY	298 M	$ 25.79	-0.19 %	$ 2.21 B	USA
American Well Corporation AMWL	254 M	$ 4.85	1.04 %	$ 72.7 M	USA
Allscripts Healthcare Solutions MDRX	1.5 B	-	-10.39 %	$ 886 M	USA
So-Young International SY	-1.52 M	$ 2.53	0.4 %	$ 201 M	China
OptimizeRx Corporation OPRX	71.5 M	$ 12.24	-1.21 %	$ 210 M	USA
GoodRx Holdings GDRX	792 M	$ 2.71	0.74 %	$ 1.05 B	USA
Omnicell OMCL	1.11 B	$ 45.4	-1.13 %	$ 2.09 B	USA
1Life Healthcare ONEM	623 M	-	-	$ 3.37 B	USA
Phreesia PHR	356 M	$ 16.87	-0.94 %	$ 920 M	USA
Premier PINC	263 M	$ 28.26	-	$ 2.33 B	USA
R1 RCM RCM	1.47 B	-	-	$ 3.81 B	USA
NantHealth NH	67 M	-	-46.64 %	$ 10.4 M	USA
Schrödinger SDGR	208 M	$ 17.74	-0.34 %	$ 1.29 B	USA
NextGen Healthcare NXGN	557 M	-	-	$ 1.6 B	USA
Zhongchao ZCMD	16.3 M	$ 0.45	-26.63 %	$ 2.34 M	China
Signify Health SGFY	184 M	-	-0.02 %	$ 7.21 B	USA
Streamline Health Solutions STRM	17.9 M	-	-	$ 21.4 M	USA
10x Genomics TXG	619 M	$ 16.32	0.15 %	$ 1.91 B	USA
Teladoc Health TDOC	2.57 B	$ 6.92	-1.21 %	$ 1.18 B	USA
Tabula Rasa HealthCare TRHC	300 M	-	-	$ 255 M	USA
Veeva Systems VEEV	2.36 B	$ 224.43	-0.08 %	$ 36 B	USA
SCWorx Corp. WORX	2.99 M	$ 0.19	-3.37 %	$ 277 K	USA